The idea of changing a key mission of the FDA comes amid a turf war between the FDA and the USDA over the regulation of genetically engineered animals.
The National Institutes of Health will shut down a controversial industry-funded study of moderate drinking and heart disease after a task force found severe ethical and scientific lapses in the study’s planning and execution, the agency’s director said Friday.
Tech giants have developed speech recognition and machine learning technologies that allow doctors to automatically transcribe audio recordings.
Dr. Thomas Parran Jr. has been called an architect of the syphilis experiments on black men and women in Tuskegee, Alabama.
The unusual manner in which the Golden State Killer case was cracked has sparked wonderment — as well as privacy concerns about genetic information.
An analysis of more than five years of Medicare Part D and Medicaid prescription data found that after states legalized weed, the number of opioid prescriptions and the daily dose of opioids went way down.
Production of injectable opioids has nearly ground to a halt due to manufacturing problems, creating a shortage of staple medications used to treat a wide array of patients.
The sole influenza vaccine made in cell culture in the United States may have worked about 20 percent better this flu season than the standard vaccines made in eggs, Food and Drug Administration Commissioner Scott Gottlieb said Thursday.
The Centers for Disease Control and Prevention is asking Congress for money for a new building to house the laboratories that work on the deadliest pathogens known to humankind.
It’s too soon to say the flu season has peaked, but it’s at least possible it may have plateaued.
